News | March 02, 2022
USFDA issues new clinical trial guidelines for cancer treatments
USFDA's industry recommendations and cancer Moonshot aim to improve lives of patients and their families
USFDA's industry recommendations and cancer Moonshot aim to improve lives of patients and their families
Patients can use the wearable, non-invasive device to measure six body parameters including blood glucose, blood pressure, heart rate, blood oxygen, respiratory rate and 6-lead ECG, from the comfort of their home
This has further strengthened its manufacturing presence in the United States of America
If approved, Opdivo plus chemotherapy would be the first neoadjuvant immunotherapy-based option for patients with resectable non-small cell lung cancer in the U.S.
High level of vaccine efficacy maintained over a 6-month period of surveillance
This collaboration aims at capturing translational disease insights from large external healthcare biobanks and maximizing value of data for drug discovery and precision medicine
This innovative biomanufacturing technology will help to deliver cost-effective viral production that is unmatched in the industry
The company, already scaling across Europe, plans to accelerate the deployment of its medication reconciliation platform in the United States
These results are being presented at the 2022 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
N Yuvraj, Joint Secretary, Dept of Pharmaceuticals, Satish Reddy, Chairman, Dr Reddy’s Laboratories; Kiran Mazumdar Shaw, Executive Chairperson, Biocon Group; Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines and Shravil Patel, MD, Zydus Lifesciences discuss the way forward for the India pharma industry
Subscribe To Our Newsletter & Stay Updated
